Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis. Kunkel A, Fischer M, Faiss J, Dähne D, Köhler W, Faiss JH Front Neurol. 2015; 6:97. Epub 2015 May 11. PMID: 26029156. Abstract CommentRecommendBookmarkWatch